MoneyWorks4Me

Alembic Pharmaceuticals’ arm receives approval from USFDA for Glycopyrrolate tablets

04 Dec 2018 Evaluate

Alembic Pharmaceuticals’ wholly owned subsidiary, Orit Laboratories LLC has received US Food & Drug Administration (USFDA) approval for Glycopyrrolate tablets USP, 1 mg and 2 mg.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..